JP Morgan 43rd Annual Healthcare Conference
JP Morgan 43rd Annual Healthcare Conference 13-16 January 2025 San Francisco, US CEO Simon Kerry and Head of Business Development Cora Griffin attending
This author has not written his bio yet.
But we are proud to say that oncotron contributed 19 entries already.
JP Morgan 43rd Annual Healthcare Conference 13-16 January 2025 San Francisco, US CEO Simon Kerry and Head of Business Development Cora Griffin attending
2024 has been a transformational year for Curve. We kicked off the year with a significant Series A financing, raising £40.5 million from a world class syndicate which includes our existing blue chip investors Advent Life Sciences and Epidarex Capital, alongside new investment from Pfizer Ventures, Columbus Venture Partners and British Patient Capital. The financing […]
London Life Sciences Week 17-21 November 2024 London, UK CEO Simon Kerry and Head of Business Development Cora Griffin attending
BIO-Europe 2024 4-6 November 2024 Stockholm, Sweden CEO Simon Kerry and Head of Business Development Cora Griffin attending
Southampton, UK, 9 October 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the appointment of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer. This continues Curve’s strong momentum expanding its leadership team following the recent appointments of Andre Hoekema and Cora Griffin, joining as Chair of the Board and Head of Business Development respectively.
Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the further strengthening of its leadership team with the appointments of Andre Hoekema as Chair of the Board and Cora Griffin as Head of Business Development.
Accomplished CFO and COO with proven track record in the biotech and pharmaceutical industry Strengthens Curve’s Leadership Team following £40.5 million Series A financing Southampton, UK, 9 July 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the […]
Biotech CEO Summit Europe 27-29 May 2024 Barcelona, Spain Simon Kerry, CEO, attending.
Bio€quity Europe 2024 12-14 May 2024 San Sebastián, Spain Simon Kerry, CEO, delivering presentation: 13 May, 15.00pm-15.10pm CEST, Room 9 Simon also participating in McKinsey panel: ‘Learnings on how to Rise above the Noise’, 11.30am-12.30pm CEST
BioTrinity 2024 23-25 April 2024 London, UK Simon Kerry, CEO, attended.
© Curve Therapeutics
Website by FisherPaul